| Date Filed | Type | Description |
| 05/18/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 05/14/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/06/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/06/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 05/06/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 05/06/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/05/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/01/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 04/29/2020 |
8-K
| Other Events |
| 04/29/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/21/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 04/02/2020 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 04/02/2020 |
SC 13D/A
| Access Industries Holdings LLC reports a 7.5% stake in Neon Therapeutics, Inc. |
| 03/31/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 03/31/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 03/31/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 03/27/2020 |
SC 13D/A
| Access Industries Holdings LLC reports a 8.8% stake in Neon Therapeutics, Inc. |
| 03/23/2020 |
SC 13G
| JFL Capital Management LP reports a 5.3% stake in Neon Therapeutics, Inc. |
| 03/02/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 03/02/2020 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/02/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/02/2020 |
8-K
| Quarterly results |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| FMR LLC reports a 5.4% stake in NEON THERAPEUTICS INC |
| 01/27/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0% stake in NEON THERAPEUTICS, INC. |
| 01/23/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/23/2020 |
SC 13D
| BioNTech SE reports a 36.2% stake in NEON THERAPEUTICS, INC. |
| 01/16/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/16/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/16/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/16/2020 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/16/2020 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
|